|
|
|
Volumn 7, Issue 6, 2006, Pages 516-517
|
|
Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Against the proposal.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
FLUOROURACIL;
ADJUVANT CHEMOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
COLON TUMOR;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
HUMAN;
MULTIMODALITY CANCER THERAPY;
NOTE;
PATHOLOGY;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
ANTIMETABOLITES, ANTINEOPLASTIC;
CHEMOTHERAPY, ADJUVANT;
COLONIC NEOPLASMS;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FLUOROURACIL;
HUMANS;
NEOPLASM STAGING;
PRACTICE GUIDELINES;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 33745481898
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (23)
|
|
References (0)
|
